BenevolentBio’s artificial intelligence could discover a better treatment for ALS

 What if the drug that could effectively treat amyotrophic lateral sclerosis, the paralyzing neurological disease that skyrocketed into the public consciousness thanks to the ice bucket challenge, already exists? That’s the question confronting Jackie Hunter, CEO of BenevolentBio. Hunter runs the biomedical arm of the artificial intelligence firm BenevolentAI, applying machine learning… Read More